JNJ
Johnson & Johnson
PEG ratio, current and historical analysis
- Stocks
- Healthcare
- NYSE: JNJ
- PEG Ratio
JNJ's PEG ratio is unavailable because the earnings growth data is negative or zero. Going back to December 2025, Johnson & Johnson had a PEG ratio of 0.21.
JNJ PEG ratio history
Historically, Johnson & Johnson shows a PEG ratio averaging 5.21 across the past ten years. The ten years high occurred in the Dec 2019 quarter at 63.7, reflecting maximum valuation relative to growth. The minimum was hit in the Dec 2018 quarter at 0.02, indicating optimal value relative to growth during that period.
Johnson & Johnson PEG ratio by year
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | 0.21 | 18.65 | 90.6% |
| 2024 | N/A | 24.84 | -57.9% |
| 2023 | 0.11 | 11.29 | 103.2% |
| 2023 | N/A | 25.86 | -13.9% |
| 2022 | 0.51 | 21.57 | 41.9% |
| 2021 | N/A | 28.15 | -2.3% |
| 2019 | 63.7 | 25.48 | 0.4% |
| 2018 | 0.02 | 22.33 | 1,087.5% |
| 2017 | N/A | 291.08 | -92.1% |
| 2017 | 2.22 | 19.07 | 8.6% |
| 2016 | N/A | 18.47 | -4.1% |
| 2014 | 1.01 | 18.11 | 17.9% |
| 2013 | 0.75 | 18.77 | 24.9% |
| 2012 | 1.56 | 17.63 | 11.3% |
| 2012 | N/A | 18.53 | -27% |
Johnson & Johnson PEG ratio by quarter (TTM)
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Mar 2026 | N/A | 27.54 | -3.6% |
| Dec 2025 | 0.21 | 18.65 | 90.6% |
| Sep 2025 | 0.24 | 17.23 | 73% |
| Jun 2025 | N/A | 16.2 | -38.2% |
| Mar 2025 | N/A | 18.07 | -40.6% |
| Dec 2024 | N/A | 24.84 | -57.9% |
| Sep 2024 | N/A | 26.77 | -55.7% |
| Jun 2024 | 0.05 | 9.6 | 205.2% |
| Mar 2024 | 0.05 | 10.37 | 215.3% |
| Dec 2023 | 0.11 | 11.29 | 103.2% |
| Oct 2023 | 0.13 | 11.44 | 86.4% |
| Jul 2023 | N/A | 33.17 | -28.6% |
| Apr 2023 | N/A | 32.02 | -35.8% |
| Jan 2023 | N/A | 25.86 | -13.9% |
| Oct 2022 | 2.91 | 22.38 | 7.7% |
JNJ average PEG ratio chart
PEG comparison
JNJ EPS growth
JNJ Price vs fair value
JNJ PEG vs peers
| Stock name | PEG ratio | Market cap |
|---|---|---|
| LLY ELI LILLY & Co | 0.3 | $1.04T |
| GILD Gilead Sciences Inc | 0.3 | $155.03B |
| SYK Stryker Corp | 2.11 | $116.81B |
| NVS Novartis AG | 2.31 | $284.17B |
| MDT Medtronic plc | 6.41 | $101.47B |
| PFE Pfizer Inc | N/A | $142.94B |
| MRK Merck & Co Inc | N/A | $285.22B |
| ABT Abbott Laboratories | N/A | $152.98B |
| JNJ Johnson & Johnson | N/A | $556.77B |
Frequently asked questions
What is Johnson & Johnson's PEG ratio?
JNJ's PEG ratio is unavailable because EPS growth data is negative or not present.
What is the 3-year average PEG ratio for Johnson & Johnson (JNJ)?
Over the last 3 years, JNJ's PEG ratio has settled near 0.13.
What is the 5-year average PEG ratio for Johnson & Johnson (JNJ)?
Over the last 5 years, JNJ's PEG ratio has settled near 1.51.
What is the highest PEG ratio for JNJ?
In the last ten years, JNJ's peak PEG ratio of 63.7 was recorded in the Dec 2019 quarter.
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.